Opioids

Insys Therapeutics and its former vice president of sales Alec Burlakoff will pay $9.5 million to settle claims that they paid doctors lucrative “speaker fees” in exchange for the doctors writing prescriptions for Insys’ flagship drug, Subsys, “a fentanyl drug,” the Arizona attorney general said.

O PHOENIX — Insys Therapeutics and its former vice president of sales Alec Burlakoff will pay$9.5 million** to settle claims that they paid doctors lucrative “speaker fees” in exchange for the doctors writing prescriptions for Insys’ flagship drug, Subsys, “a fentanyl drug,” the Arizona attorney general said.

Categories / Business, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.